Biontech Names New CEO, Lowers Forecast
Biontech has named Guido Oelkers as its new CEO. This follows Uğur Şahin leaving the company. The company’s future is now uncertain.
Uğur Şahin, one of the founders of Biontech, is leaving his role as CEO. Guido Oelkers will take over as the new CEO. Biontech expects Oelkers to help the company find new ways to make money. Sales from their vaccines are decreasing. The company has changed its financial plans because of this leadership change.
Summarized from the sources above. Read the originals for the full story.
Highlights
Uğur Şahin Steps Down
Uğur Şahin is leaving his role as CEO of BioNTech.
Guido Oelkers Takes Over
Guido Oelkers is now the CEO of BioNTech.
Uncertain Future for BioNTech
The company’s future direction is currently uncertain.
Sales Decline, Forecast Lowered
BioNTech expects declining vaccine sales and has lowered its forecast.
New CEO to Drive Revenue
Guido Oelkers is expected to create new revenue streams.